# Treatment of Mycobacterium Xenopi Pulmonary Infection

> **NCT01298336** · PHASE3 · COMPLETED · sponsor: **Centre Hospitalier Universitaire, Amiens** · enrollment: 92 (actual)

## Conditions studied

- Atypical; Mycobacterium, Pulmonary, Tuberculous

## Interventions

- **DRUG:** Clarithromycin
- **DRUG:** Moxifloxacin

## Key facts

- **NCT ID:** NCT01298336
- **Lead sponsor:** Centre Hospitalier Universitaire, Amiens
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-03-02
- **Primary completion:** 2019-03
- **Final completion:** 2019-03
- **Target enrollment:** 92 (ACTUAL)
- **Last updated:** 2025-11-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01298336

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01298336, "Treatment of Mycobacterium Xenopi Pulmonary Infection". Retrieved via AI Analytics 2026-09-08 from https://api.ai-analytics.org/clinical/NCT01298336. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*